We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.09%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.42B
AUM Growth
+$199M
(+3.2%)
Cap. Flow
+$34.8M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
385
New
15
Increased
156
Reduced
158
Closed
12
Avg Time Held
3
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$23M |
| 2 |
Danaher
DHR
|
+$18.9M |
| 3 |
The Marzetti Company
MZTI
|
+$16.2M |
| 4 |
Marsh
MRSH
|
+$15.8M |
| 5 |
CubeSmart
CUBE
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IPG Photonics
IPGP
|
+$23.2M |
| 2 |
PRXL
Parexel International Corp
PRXL
|
+$22.7M |
| 3 |
Toro Company
TTC
|
+$22.6M |
| 4 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$19.9M |
| 5 |
National Health Investors
NHI
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.05% |
| 2 | Healthcare | 17.17% |
| 3 | Technology | 14.64% |
| 4 | Industrials | 13.43% |
| 5 | Consumer Discretionary | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Gilead Sciences
GILD
$193B
| – | – |
-3,395
| Closed | -$240K | – |
|
377
LKQ Corp
LKQ
$5.63B
| – | – |
-69,330
| Closed | -$2.28M | – |
|
|
378
National Health Investors
NHI
$3.25B
| – | – |
-219,124
| Closed | -$17.4M | – |
|
379
United Natural Foods
UNFI
$2.87B
| – | – |
-244,840
| Closed | -$8.99M | – |
|
380
Varex Imaging
VREX
$783M
| – | – |
-14,011
| Closed | -$474K | – |
|
|
SVU
381
DELISTED
SUPERVALU Inc.
SVU
| – | – |
-5,714
| Closed | -$132K | – |
|
|
PRXL
382
DELISTED
Parexel International Corp
PRXL
| – | – |
-261,602
| Closed | -$22.7M | – |
|
|
DFT
383
DELISTED
DuPont Fabros Technology Inc.
DFT
| – | – |
-324,940
| Closed | -$19.9M | – |
|
384
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-7,412
| Closed | -$598K | – |
|
|
WFM
385
DELISTED
Whole Foods Market Inc
WFM
| – | – |
-263,103
| Closed | -$11.1M | – |
|
Similar funds
Boston Trust Walden's Q3 2017 Portfolio in Review
As of Q3 2017, Boston Trust Walden held 385 positions worth $6.42B, up 3.2% from $6.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Trust Walden's Q3 2017 filing shows 15 new, 156 increased, 158 reduced and 12 closed positions. Its largest new stake was The Marzetti Company: 134,349 shares worth $16.1M. The largest sale was IPG Photonics, an estimated $23.2M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
- Boston Trust Walden's largest Q3 2017 buy was The Marzetti Company: 134,349 shares worth $16.1M.
- Boston Trust Walden added most to Estee Lauder in Q3 2017, an estimated $23M increase.
- Boston Trust Walden's biggest Q3 2017 reduction was IPG Photonics, cutting an estimated $23.2M.
- Boston Trust Walden fully exited Parexel International Corp in Q3 2017, selling an estimated $22.7M.
- Boston Trust Walden's ten largest holdings make up 17% of its $6.42B portfolio in Q3 2017.
- Boston Trust Walden opened 15 new positions and closed 12 in Q3 2017.
- Boston Trust Walden's portfolio value rose 3.2% quarter-over-quarter to $6.42B.
Based on Boston Trust Walden's 13F filing for Q3 2017, filed 13 Oct 2017.